Anatara Lifesciences Ltd has released a press release.
Anatara retains global market for Detach
Filed with ASX ·
6ix hasn’t read this filing yet.
Anatara Lifesciences Ltd on 6ix
In the deck
Story so far
Earlier from Anatara Lifesciences
- Response to ASX Appendix 4C Query
- Successful proof of concept studies
- R&D Tax Refund Received
- Chief Executive Officer Appointment
- APVMA approval for Detach
Later from Anatara Lifesciences
- Anatara Animal Health Asset Update
- Anatara Animal Health Assets Update
- Appendix 4E and Financial Report
- Anatara reports statistically significant animal studies
- Anatara achieves preclinical milestone
Follow Anatara Lifesciences into a list and get an email when it puts out news.
Follow Anatara Lifesciences